Cargando…
Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway
BACKGROUND: Type 2 diabetes (T2D) is an independent risk factor for Alzheimer's disease (AD). Exendin-4 (Ex-4), a widely used glucagon-like peptide-1 receptor agonist drug in the treatment of T2D, has been demonstrated the therapeutic effects on diabetic encephalopathy (DE). Especially, the Ex...
Autores principales: | Kang, Xiaonan, Wang, Dan, Zhang, Lu, Huang, Teng, Liu, Siyue, Feng, Xiaohui, Guo, Yaoyao, Zhang, Ziyin, Wang, Zhongjing, Ren, Huihui, Yuan, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478475/ https://www.ncbi.nlm.nih.gov/pubmed/37667187 http://dx.doi.org/10.1186/s10020-023-00718-2 |
Ejemplares similares
-
Wnt3a upregulates brain-derived insulin by increasing NeuroD1 via Wnt/β-catenin signaling in the hypothalamus
por: Lee, Jaemeun, et al.
Publicado: (2016) -
Failure of observing NeuroD1-induced microglia-to-neuron conversion in vitro is not attributed to the low NeuroD1 expression level
por: Rao, Yanxia, et al.
Publicado: (2022) -
Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013) -
Hes6 Is Required for the Neurogenic Activity of Neurogenin and NeuroD
por: Murai, Kasumi, et al.
Publicado: (2011) -
Mechanistic Insights in NeuroD Potentiation of Mineralocorticoid Receptor Signaling
por: van Weert, Lisa T. C. M., et al.
Publicado: (2019)